| Title : The history of acetylcholinesterase inhibitors in the treatment of myasthenia gravis - Katz_2020_Neuropharmacol__108303 |
| Author(s) : Katz NK , Barohn RJ |
| Ref : Neuropharmacology , :108303 , 2020 |
| Abstract : |
| PubMedSearch : Katz_2020_Neuropharmacol__108303 |
| PubMedID: 32918950 |
| Title : Treatment of Myasthenia Gravis - Farmakidis_2018_Neurol.Clin_36_311 |
| Author(s) : Farmakidis C , Pasnoor M , Dimachkie MM , Barohn RJ |
| Ref : Neurol Clin , 36 :311 , 2018 |
| Abstract : |
| PubMedSearch : Farmakidis_2018_Neurol.Clin_36_311 |
| PubMedID: 29655452 |
| Title : Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies - Rivner_2018_Neurol.Clin_36_293 |
| Author(s) : Rivner MH , Pasnoor M , Dimachkie MM , Barohn RJ , Mei L |
| Ref : Neurol Clin , 36 :293 , 2018 |
| Abstract : |
| PubMedSearch : Rivner_2018_Neurol.Clin_36_293 |
| PubMedID: 29655451 |
| Title : Congenital Myasthenic Syndromes: a Clinical and Treatment Approach - Farmakidis_2018_Curr.Treat.Options.Neurol_20_36 |
| Author(s) : Farmakidis C , Pasnoor M , Barohn RJ , Dimachkie MM |
| Ref : Curr Treat Options Neurol , 20 :36 , 2018 |
| Abstract : |
| PubMedSearch : Farmakidis_2018_Curr.Treat.Options.Neurol_20_36 |
| PubMedID: 30032336 |
| Title : Treatment and clinical research in myasthenia gravis: how far have we come? - Barohn_2008_Ann.N.Y.Acad.Sci_1132_225 |
| Author(s) : Barohn RJ |
| Ref : Annals of the New York Academy of Sciences , 1132 :225 , 2008 |
| Abstract : |
| PubMedSearch : Barohn_2008_Ann.N.Y.Acad.Sci_1132_225 |
| PubMedID: 18567872 |
| Title : Management of myasthenia gravis - Saperstein_2004_Semin.Neurol_24_41 |
| Author(s) : Saperstein DS , Barohn RJ |
| Ref : Semin Neurol , 24 :41 , 2004 |
| Abstract : |
| PubMedSearch : Saperstein_2004_Semin.Neurol_24_41 |
| PubMedID: 15229791 |